Press release
SZ Pharma Delivers 600 sqm FDA-Certified Cleanroom Facility in Colombia
Chinese cleanroom specialist completes full turnkey medical device manufacturing project for the Latin American marketImage: https://www.abnewswire.com/upload/2026/06/01117de2fb07fc1fa490bb2caa9c8a74.jpg
Suzhou Pharma Machinery Co., Ltd. (SZ Pharma) has completed delivery and commissioned a 600-square-meter cleanroom facility in Colombia [https://www.sz-pharma.com/from-planning-to-operation-full-chain-delivery-of-the-colombian-cleanroom-project.html] for a medical instruments manufacturer. The project, finalized in 2025, covers injection molding, precision assembly, and aseptic packaging operations. The facility has received local FDA certification, confirming compliance with both Colombian and international regulatory standards.
The facility operates at ISO 7 and ISO 8 cleanliness levels in line with ISO 14644 international standards. SZ Pharma designed a zoned layout that physically separates injection molding, assembly, packaging, and auxiliary areas. Each production zone functions as a contained unit, preventing cross-contamination while keeping the manufacturing process continuous.
Environmental stability inside the facility depends on H14 high-efficiency filters that handle deep air purification. Dedicated systems control temperature, humidity, and pressure differentials throughout the production areas. Critical structural junctions received specialized sealing treatments to prevent air leakage, and the assembly zones include anti-static installations to protect sensitive precision components.
The local FDA certification was a primary objective of the build. The certification confirms that suspended particle and contaminant detection values at the facility fall well below international maximum thresholds. With this approval in place, the client now has the regulatory standing to expand distribution of medical consumables across Latin America.
SZ Pharma managed the entire project lifecycle, from initial planning and architectural design through material shipment and on-site construction. Following the build phase, Suzhou Pharma Machinery directed the local certification process and operational debugging. SZ Pharma continues to provide technical support and maintenance services to maintain the long-term environmental stability of the cleanroom.
"Colombia has been building strong quality supervision systems for the medical sector, and this facility positions our client to operate at the highest level within that market. We managed every stage of this project - from the structural design to final certification - and the result reflects the technical standard we hold for every installation we deliver." - Spokesperson, Suzhou Pharma Machinery Co., Ltd.
The Colombia project adds to SZ Pharma's record of full-chain cleanroom delivery across North America, South America, Europe, Asia, and Africa. Suzhou Pharma Machinery specializes in turnkey cleanroom builds and modular systems for pharmaceutical, medical device, food, hemp, and laboratory clients worldwide.
Learn more at: https://www.sz-pharma.com/from-planning-to-operation-full-chain-delivery-of-the-colombian-cleanroom-project.html
About Suzhou Pharma Machinery Co., Ltd.
Suzhou Pharma Machinery Co., Ltd. (SZ Pharma) is a cleanroom construction company and pharmaceutical equipment manufacturer based in Suzhou, China. Suzhou Pharma Machinery delivers turnkey cleanroom builds, modular cleanroom systems, and extraction machinery for the pharmaceutical, medical device, food, hemp, and laboratory industries. SZ Pharma manages full-scale engineering projects across multiple regions, including North America, South America, Europe, Asia, and Africa.
Inquiries can be sent to pharma@sz-pharma.com or visit https://www.sz-pharma.com/
For updates, follow Suzhou Pharma Machinery Co., Ltd. on social media:
Twitter @pharmaclean
LinkedIn @suzhou-pharma-machinery
YouTube @pharmamachinery2458
Media Contact
Company Name: Suzhou Pharma Machinery Co., Ltd.
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=sz-pharma-delivers-600-sqm-fdacertified-cleanroom-facility-in-colombia]
Country: China
Website: http://sz-pharma.com
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release SZ Pharma Delivers 600 sqm FDA-Certified Cleanroom Facility in Colombia here
News-ID: 4548269 • Views: …
More Releases from ABNewswire
Sacramento, CA Printing Cost Breakdown: What Is Really Being Paid For: Materials …
Royal Prints breaks down what Sacramento businesses pay for in print orders, from materials and sign printing to labor, turnaround, and delivery, with no hidden fees.
SACRAMENTO, CA - August 16, 2026 - Print quotes across Sacramento continue to puzzle local business owners. A business card order from one printing company Sacramento locals rely on might come back at $85 for 500 pieces, while another vendor quotes $220 for the exact…
Independent Etsy Brand Naughty Chicken Tees Proves Small Business Creativity Can …
Naughty Chicken Tees exemplifies the growing power of independent creators in the American fashion market, offering chicken-themed graphic tees that rival larger brands in design quality and customer appeal. The Etsy storefront has become a destination for shoppers seeking original apparel that cannot be found on conventional retail shelves.
The American fashion industry has traditionally been dominated by large corporations with massive marketing budgets and extensive retail networks. But the rise…
Bob Kevess, MD, Examines How Patient-Centered Primary Care Supports Better Healt …
Healthcare leader discusses how communication, continuity, and preventive care strengthen the relationship between physicians and adult patients
BERKELEY, Calif. - Aug 15, 2026 - As healthcare systems continue shifting toward value-based care and prevention-focused models, physicians and healthcare organizations are placing renewed emphasis on patient-centered primary care. Rather than focusing solely on diagnosing and treating disease, this approach encourages long-term partnerships between patients and healthcare providers, recognizing that informed, engaged individuals…
Local Practice Offering Teen Therapy in Claremont, CA Addresses Growing Mental H …
Image: http://www.abnewswire.com/pressreleases/wp-content/uploads/2026/08/2026
Claremont, CA - August 14, 2026 - Today's teenagers face a complex landscape of academic pressure, social media exposure, identity challenges, and family transitions that can take a serious toll on mental health. Aspire Therapy Center - Claremont, CA Counselor office, founded in 2012 with its Claremont location opening in 2018, has become a trusted resource for adolescents and their families navigating these demands. Under the leadership of Melissa…
More Releases for Pharma
Schizophrenia Market Gains Momentum with Expanding Pipeline and Investment Poten …
The Key Schizophrenia Companies in the market include - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Acadia Pharmaceuticals, Boehringer Ingelheim, Cerevel Therapeutics, AstraZeneca, Eli Lilly and Company, Karuna Therapeutics, Neurocrine Biosciences, and others.
DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2036" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed…
Schizophrenia Market: Expanding Revenue Landscape to 2034 - DelveInsight | Teva …
The Key Schizophrenia Companies in the market inlclude - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Reviva Pharmaceuticals, and others.
DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2034" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed insights into the disease, including historical and projected epidemiology, helping stakeholders understand the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
